Literature DB >> 17693583

Infection of hematopoietic progenitor cells by HIV-1 subtype C, and its association with anemia in southern Africa.

Andrew D Redd1, Ava Avalos, Max Essex.   

Abstract

Reports from southern Africa, an area in which human immunodeficiency virus type 1 (HIV-1) infection is caused almost exclusively by subtype C (HIV-1C), have shown increased rates of anemia in HIV-infected populations compared with similar acquired immunodeficiency syndrome (AIDS) patients in the United States, an area predominantly infected with subtype B (HIV-1B). Recent findings by our group demonstrated a direct association between HIV-1 infection and hematopoietic progenitor cell health in Botswana. Therefore, using a single-colony infection assay and quantitative proviral analysis, we examined whether HIV-1C could infect hematopoietic progenitor cells (HPCs) and whether this phenotype was associated with the higher rates of anemia found in southern Africa. The results show that a significant number of HIV-1C, but not HIV-1B, isolates can infect HPCs in vitro (P < .05). In addition, a portion of HIV-1C-positive Africans had infected progenitor cell populations in vivo, which was associated with higher rates of anemia in these patients (P < .05). This represents a difference in cell tropism between 2 geographically separate and distinct HIV-1 subtypes. The association of this hematotropic phenotype with higher rates of anemia should be considered when examining anti-HIV drug treatment regimens in HIV-1C-predominant areas, such as southern Africa.

Entities:  

Mesh:

Year:  2007        PMID: 17693583      PMCID: PMC2200905          DOI: 10.1182/blood-2007-04-086314

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  43 in total

1.  Protease inhibitors stimulate hematopoiesis and decrease apoptosis and ICE expression in CD34(+) cells.

Authors:  E M Sloand; J Maciejewski; P Kumar; S Kim; A Chaudhuri; N Young
Journal:  Blood       Date:  2000-10-15       Impact factor: 22.113

Review 2.  The influence of human immunodeficiency virus-1 on hematopoiesis.

Authors:  A Moses; J Nelson; G C Bagby
Journal:  Blood       Date:  1998-03-01       Impact factor: 22.113

Review 3.  Hematologic Aspects of HIV/AIDS.

Authors:  A M Levine; D T Scadden; J A Zaia; A Krishnan
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2001

Review 4.  Adverse effects of antiretroviral therapy.

Authors:  A Carr; D A Cooper
Journal:  Lancet       Date:  2000-10-21       Impact factor: 79.321

5.  Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?

Authors:  V Novitsky; U R Smith; P Gilbert; M F McLane; P Chigwedere; C Williamson; T Ndung'u; I Klein; S Y Chang; T Peter; I Thior; B T Foley; S Gaolekwe; N Rybak; S Gaseitsiwe; F Vannberg; R Marlink; T H Lee; M Essex
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  Reversal of human immunodeficiency virus type 1-associated hematosuppression by effective antiretroviral therapy.

Authors:  S S Huang; J D Barbour; S G Deeks; J S Huang; R M Grant; V L Ng; J M McCune
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

7.  Construction and analysis of an infectious human Immunodeficiency virus type 1 subtype C molecular clone.

Authors:  T Ndung'u; B Renjifo; M Essex
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

8.  Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C.

Authors:  V Novitsky; H Cao; N Rybak; P Gilbert; M F McLane; S Gaolekwe; T Peter; I Thior; T Ndung'u; R Marlink; T H Lee; M Essex
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Human Mast cell progenitors can be infected by macrophagetropic human immunodeficiency virus type 1 and retain virus with maturation in vitro.

Authors:  N Bannert; M Farzan; D S Friend; H Ochi; K S Price; J Sodroski; J A Boyce
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  Improvement of interleukin 2 production, clonogenic capability and restoration of stromal cell function in human immunodeficiency virus-type-1 patients after highly active antiretroviral therapy.

Authors:  Antonella Isgrò; Alessandro Aiuti; Ivano Mezzaroma; Maria Addesso; Elisabetta Riva; Antonello Giovannetti; Francesca Mazzetta; Cecilia Alario; Annamaria Mazzone; Luigi Ruco; Fernando Aiuti
Journal:  Br J Haematol       Date:  2002-09       Impact factor: 6.998

View more
  25 in total

1.  Short communication: Colony-forming hematopoietic progenitor cells are not preferentially infected by HIV type 1 subtypes A and D in vivo.

Authors:  Caroline E Mullis; Amy E Oliver; Leigh Anne Eller; David Guwatudde; Amy C Mueller; Michael A Eller; Hannah Kibuuka; Merlin Robb; Thomas C Quinn; Andrew D Redd
Journal:  AIDS Res Hum Retroviruses       Date:  2012-02-02       Impact factor: 2.205

2.  HIV-1 DNA is detected in bone marrow populations containing CD4+ T cells but is not found in purified CD34+ hematopoietic progenitor cells in most patients on antiretroviral therapy.

Authors:  Christine M Durand; Gabriel Ghiaur; Janet D Siliciano; S Alireza Rabi; Evelyn E Eisele; Maria Salgado; Liang Shan; Jun F Lai; Hao Zhang; Joseph Margolick; Richard J Jones; Joel E Gallant; Richard F Ambinder; Robert F Siliciano
Journal:  J Infect Dis       Date:  2012-01-24       Impact factor: 5.226

3.  Erythropoiesis in HIV-infected and uninfected Malawian children with severe anemia.

Authors:  Job C J Calis; Kamija S Phiri; Raymond J W M Vet; Rob J de Haan; Francis Munthali; Robert J Kraaijenhagen; Paul J M Hulshof; Malcolm E Molyneux; Bernard J Brabin; Michaël Boele van Hensbroek; Imelda Bates
Journal:  AIDS       Date:  2010-11-27       Impact factor: 4.177

4.  Hematopoietic precursor cells isolated from patients on long-term suppressive HIV therapy did not contain HIV-1 DNA.

Authors:  Lina Josefsson; Susanne Eriksson; Elizabeth Sinclair; Terence Ho; Maudi Killian; Lorrie Epling; Wei Shao; Bradley Lewis; Peter Bacchetti; Lisa Loeb; Jeff Custer; Lauren Poole; Frederick M Hecht; Sarah Palmer
Journal:  J Infect Dis       Date:  2012-04-25       Impact factor: 5.226

Review 5.  Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages.

Authors:  Davide Gibellini; Alberto Clò; Silvia Morini; Anna Miserocchi; Cristina Ponti; Maria Carla Re
Journal:  World J Virol       Date:  2013-05-12

6.  Practical Management of HIV-Associated Anemia in Resource-Limited Settings: Prospective Observational Evaluation of a New Mozambican Guideline.

Authors:  Paula E Brentlinger; Wilson P Silva; Sten H Vermund; Emilio Valverde; Manuel Buene; Troy D Moon
Journal:  AIDS Res Hum Retroviruses       Date:  2015-08-19       Impact factor: 2.205

Review 7.  Potential implication of residual viremia in patients on effective antiretroviral therapy.

Authors:  Gautam K Sahu
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

8.  HIV-1 pathogenesis: the virus.

Authors:  Ronald Swanstrom; John Coffin
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

Review 9.  Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions.

Authors:  Nadia T Sebastian; Kathleen L Collins
Journal:  Expert Rev Anti Infect Ther       Date:  2014-09-04       Impact factor: 5.091

Review 10.  Neutropenia during HIV infection: adverse consequences and remedies.

Authors:  Xin Shi; Matthew D Sims; Michel M Hanna; Ming Xie; Peter G Gulick; Yong-Hui Zheng; Marc D Basson; Ping Zhang
Journal:  Int Rev Immunol       Date:  2014-03-21       Impact factor: 5.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.